SKINVIVE by JUVÉDERM, Allergan's hyaluronic acid microdroplet injectable, has received FDA clearance for treatment of neck lines and skin laxity. The formulation is designed to improve skin quality through hydration and subtle volumization rather than traditional bolus filler placement. The mechanism relies on precise microdroplet distribution to stimulate collagen remodeling and improve skin elasticity.
Regulatory
SKINVIVE by JUVÉDERM Gains FDA Approval for Neck Lines—New Indication Expands Filler Market
Allergan's hyaluronic acid microdroplet formulation clears for neck laxity, opening a new anatomical revenue stream for practices.
1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
FDA approval for neck lines opens a new anatomical revenue stream for practices using hyaluronic acid injectables.
For medspa practices, this approval expands the addressable market beyond the face. Neck and décolletage treatments have historically relied on laser resurfacing, RF microneedling, or off-label filler use. SKINVIVE's FDA clearance legitimizes injectable treatment of this area and creates a new per-syringe revenue opportunity. Practitioners should expect Allergan to bundle SKINVIVE with existing Juvéderm products in loyalty programs (Alle platform) to drive adoption. The indication also appeals to practices seeking to offer comprehensive facial and neck rejuvenation in a single visit.
Source: original report ↗
Frequently asked questions
Is SKINVIVE by JUVÉDERM FDA approved for neck lines?
Yes, SKINVIVE by JUVÉDERM received FDA clearance for treatment of neck lines and skin laxity. The hyaluronic acid microdroplet formulation works through precise distribution to stimulate collagen remodeling and improve skin elasticity rather than traditional bolus filler placement.
How does SKINVIVE differ from regular dermal fillers for neck treatment?
SKINVIVE uses a microdroplet formulation designed to improve skin quality through hydration and subtle volumization, focusing on collagen remodeling and elasticity rather than adding volume like traditional fillers. This makes it better suited for addressing skin laxity and fine lines on the neck and décolletage.
What are the revenue opportunities for medspa practices with SKINVIVE neck approval?
The neck and décolletage indication creates a new per-syringe revenue stream beyond facial treatments. Practices can now offer comprehensive facial and neck rejuvenation in a single visit, and Allergan is expected to bundle SKINVIVE with existing Juvéderm products through loyalty programs on the Alle platform to drive adoption.
What treatments did practices use for neck laxity before SKINVIVE approval?
Historically, neck and décolletage treatments relied on laser resurfacing, RF microneedling, or off-label filler use. SKINVIVE's FDA clearance now legitimizes injectable treatment of this area as a primary option.
Can SKINVIVE be combined with other Juvéderm products in the same treatment?
While the approval allows practices to offer comprehensive facial and neck rejuvenation in a single visit, specific combination protocols should follow Allergan's clinical guidelines. Expect bundling strategies through the Alle loyalty platform to encourage multi-product use.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.